Form4insider filings, from the source

SEC Form 4 · accession 0001104659-19-003219

Crinetics Pharmaceuticals, Inc. · CRNX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jan 22, 2019
Accepted (ET)
Jan 24, 2019 · 7:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001658247

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F3Jan 22, 2019S251,667$21.875D3,107,642ISee footnotes
Common StockF2,F3Jan 22, 2019S10,486$21.875D129,483ISee footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses